期刊文献+

新型乙酰胆碱酯酶抑制剂的分子对接研究

Molecular Docking of Novel Acetylcholinesterase Inhibitors
下载PDF
导出
摘要 构建了乙酰胆碱酯酶抑制剂药效团模型,并基于此模型进行新型乙酰胆碱酯酶抑制剂的分子设计。用MVD软件进行分子对接,预测设计分子与乙酰胆碱酯酶的结合活性。通过计算发现,基于此药效团设计的小分子9与14乙酰胆碱酯酶具有较好的结合活性。 A series of acetylcholinesterase inhibitors(AChEI) were successfully designed based on the construction of a pharmacophore model of AChEI.Both these inhibitors and acetylcholinesterase(AChE) were docked by using MVD software to predict their binding abilities with AChE.Among these small molecules,9 and 14 have the strongest binding affinity with AChE.
出处 《安徽化工》 CAS 2011年第3期26-28,32,共4页 Anhui Chemical Industry
关键词 阿尔茨海默病 乙酰胆碱酯酶抑制剂 多奈哌齐 分子对接 Alzheimer's disease AChEI donepezil molecular docking
  • 相关文献

参考文献14

  • 1段金海,汪华侨,陈少琼,徐杰,林贤,康庄,姚志彬.阿尔茨海默病患者脑白质损害与认知功能的关系[J].中华神经科杂志,2006,39(2):76-79. 被引量:8
  • 2Volger BW. Alternatives in the treatment of memory loss in patients with Alzheimer' s disease[J]. Clin Pharm, 1991,10(6 ): 447-456.
  • 3Trinh Nil, Hoblyn M J, Mhanty MP, et al. Egieacy of Cholinesterase inhibitors in the Treatment of Neuropsy-ehiatrie Symptoms and Functional Impairment in Alzheimer' s disease[J]. JA MA,2003,289 (2): 210-216.
  • 4L.Piazzi, A.Rampa, A.Bisi, S.Gobbi, F.Belluti,A.Cavalli, M.Bartolini,V.Andrisano. 3 - (4- {[Benzyl ( methyl )amino]methyl}phenyl )-6, 7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β -Amyloid Aggregation:A Dual Function Lead for Alzheimer's Disease Therapy[J]. J Med Chem, 2003,46: 2279-2282.
  • 5Kryger G, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with E2020: implications for the design of new anti-Alzheimer drugs[J]. Structure, 1999,7 (3): 297-307.
  • 6王淑平,史宇翔.治疗阿尔茨海默病的胆碱酯酶抑制剂的研究进展[J].中国药业,2005,14(10):78-79. 被引量:5
  • 7Pelayo Camps, Xavier Formosa, Caries Galdeano,Tania Gomez. Novel Donepezil-Based Inhibitors of Acetyl-and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation [J]. J Med Chem,2008,51 ( 12): 3588-3598.
  • 8Gane PJ, Dean PM. Recently advances in structure-based rational drug design[J]. Curr Opin Sruct Biol,2000,10(4):401-404.
  • 9叶德举,罗小民,沈建华,朱维良,沈旭,蒋华良,柳红.先导化合物的发现——整合计算机虚拟筛选、化学合成和生物测试方法[J].化学进展,2007,19(12):1939-1946. 被引量:11
  • 10Kryger G,Silman I,Sussman JL. Structure of acetylcholinesterase complexed with E2020: implications for the design of new Anti-Alzheimer drugs[J]. Sructure, 1999,7(3 ) : 297-307.

二级参考文献79

  • 1汤慈美,刘颖.帕金森病患者的智力和视空间知觉障碍[J].中华老年医学杂志,1993,12(4):200-204. 被引量:13
  • 2李洪林,沈建华,罗小民,沈旭,朱维良,王希诚,陈凯先,蒋华良.虚拟筛选与新药发现[J].生命科学,2005,17(2):125-131. 被引量:43
  • 3袁浩龙.阿耳茨海默氏病治疗药他克林[J].国外医药(合成药.生化药.制剂分册),1996,17(2):101-102. 被引量:5
  • 4Bronge L,Bogdanovic N,Wahlund LO.Postmortem MRI and histopathology of white matter changes in Alzheimer brains:A quantitative,comparative study.Dement Geriatr Cogn Disord,2002,13:205-212.
  • 5Han X,Holtzman M,McKeel DW,et al.Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease:potential role in disease pathogenesis.J Neurochem,2002,82:809-818.
  • 6Bozzali M,Falini A,Franceschi M,et al.White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.J Neurol Neurosurg Psychiatry,2002,72:742-746.
  • 7Rose SE,Chen F,Chalk JB,et al.Loss of connectivity in Alzheimer's disease:an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging.J Neurol Neurosurg Psychiatry,2000,69:528-530.
  • 8Choi SJ,Lim KO,Monteiro I,et al.Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease:a preliminary study.J Geriatr Psychiatry Neurol,2005,18:12-19.
  • 9Pearson RC,Esiri MM,Hiorns RW,et al.Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.Proc Natl Acad Sci USA,1985,82:4531-4534.
  • 10Rogers J,Morrison JH.Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.J Neurosci,1985,5:2801-2808.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部